Chintan Parekh
Overview
Explore the profile of Chintan Parekh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
545
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Le J, Park J, Ha V, Luong A, Branciamore S, Rodin A, et al.
Immunity
. 2020 Jun;
52(6):1105-1118.e9.
PMID: 32553173
The challenges in recapitulating in vivo human T cell development in laboratory models have posed a barrier to understanding human thymopoiesis. Here, we used single-cell RNA sequencing (sRNA-seq) to interrogate...
12.
Gang E, Kim H, Hsieh Y, Ruan Y, Ogana H, Lee S, et al.
Blood
. 2020 Mar;
136(2):210-223.
PMID: 32219444
Resistance to multimodal chemotherapy continues to limit the prognosis of acute lymphoblastic leukemia (ALL). This occurs in part through a process called adhesion-mediated drug resistance, which depends on ALL cell...
13.
Adam E, Kim H, Gang E, Schnair C, Lee S, Lee S, et al.
Cancers (Basel)
. 2017 Sep;
9(9).
PMID: 28891959
The quest continues for targeted therapies to reduce the morbidity of chemotherapy and to improve the response of resistant leukemia. Adhesion of acute lymphoblastic leukemia (ALL) cells to bone marrow...
14.
Moke D, Oberley M, Bhojwani D, Parekh C, Orgel E
Pediatr Blood Cancer
. 2017 Sep;
65(2).
PMID: 28876513
While early studies reported superior survival for cancer patients enrolled on clinical trials, recent findings are inconclusive. We investigated the association between enrollment on contemporary trials and event-free survival (EFS)...
15.
Assaf R, Hoffman J, Parekh C, Zhou S, Wu S
Pediatr Infect Dis J
. 2017 Jun;
36(11):1109.
PMID: 28650417
No abstract available.
16.
Parekh C, Gaynon P, Abdel-Azim H
Pediatr Blood Cancer
. 2016 Jan;
63(5):945.
PMID: 26766623
No abstract available.
17.
Casero D, Sandoval S, Seet C, Scholes J, Zhu Y, Ha V, et al.
Nat Immunol
. 2015 Oct;
16(12):1282-91.
PMID: 26502406
To elucidate the transcriptional 'landscape' that regulates human lymphoid commitment during postnatal life, we used RNA sequencing to assemble the long non-coding transcriptome across human bone marrow and thymic progenitor...
18.
Lu Z, Pannunzio N, Greisman H, Casero D, Parekh C, Lieber M
Blood
. 2015 Aug;
126(14):1730-1.
PMID: 26276666
No abstract available.
19.
Parekh C, Gaynon P, Abdel-Azim H
Pediatr Blood Cancer
. 2015 May;
62(11):2040-3.
PMID: 25976383
The role of end of induction minimal residual disease (MRD) as determined by flow cytometry for treatment assignment in pediatric T-cell acute lymphoblastic leukemia (T-ALL) is not well defined. We...
20.
Chung B, Montel-Hagen A, Ge S, Blumberg G, Kim K, Klein S, et al.
Stem Cells
. 2014 May;
32(9):2386-96.
PMID: 24801626
A system that allows manipulation of the human thymic microenvironment is needed both to elucidate the extrinsic mechanisms that control human thymopoiesis and to develop potential cell therapies for thymic...